3629 results for «214»

Filter By

3629 results

Clinical event reductions in high-risk hypertension patients treated with renal denervation

18 May 2021 – From EuroPCR 2021

Watch this session presented by Roland Schmieder in order to learn about the long-term safety and efficacy of renal denervation in high-risk subgroups from the largest renal denervation data set of real-world patients, to understand how clinical event rates could be reduced following renal denervation as compared...

Clinical event reductions in high-risk hypertension patients treated with renal denervation

BIOSTEMI: translating ultrathin DES technology into superior STEMI patient outcomes

18 May 2021 – From EuroPCR 2021

Watch this session presented by Juan F. Iglesias in order to review the role of ultrathin DES in optimising clinical outcomes in STEMI patients, to learn about the BIOSTEMI trial and its new two-year outcomes, and to assess the impact of the BIOSTEMI trial on your daily practice.

BIOSTEMI: translating ultrathin DES technology into superior STEMI patient outcomes

Stent failure - LIVE Case

11 Oct 2025 – From AICT-AsiaPCR 2025

This educational session presents a live case from Apollo Hospitals, Chennai, focusing on stent failure management. It emphasizes the critical role of imaging in optimizing treatment for in-stent restenosis, discusses essential lesion preparation tools, and reviews various therapeutic options to improve patient care.

 LIVE Educational Case from...

Stent failure - LIVE Case

Percutaneous or surgical management of post-infarction ventricular septal defects: The United Kingdom National Registry

17 Sep 2022

Elad Asher provides his take on the UK National Registry which was presented at the TCT congress 2022 by Joel Peter Giblett on behalf of the UK PIVSD investigators.

Elad Asher

Author

Elad Asher
Percutaneous or Surgical Management of Post-Infarction Ventricular Septal Defects: The United Kingdom National Registry

The PRE18FFIR trial: Coronary Plaque Activity to Predict Recurrent Events

01 Sep 2022

Alex Sticchi provides his take on the PRE18FFIR trial: Prediction of recurrent events with 18F-Sodium Fluoride to identify ruptured and high-risk coronary artery plaques in patients with myocardial infarction.

Alessandro Sticchi

Author

Alessandro Sticchi
The PRE18FFIR trial: Coronary Plaque Activity to Predict Recurrent Events

Cardiawave announces positive six-month data from valvosoft pivotal study at transcatheter cardiovascular therapeutics (TCT) conference

28 Oct 2024

EuroPCR 2024 – One-month DAPT followed by 5-month Ticagrelor monotherapy in acute coronary syndromes with DCB - results from REC-CAGEFREE II

15 May 2024

Paris, France, 14-17 May 2024. The Course Directors have selected 3 major Late Breaking Trials (LBTs) that will be presented for the first time during the 2024 edition of EuroPCR. These trials were selected on account of their design, outcomes and potential to influence daily clinical...

ECMO-CS – Extracorporeal membrane oxygenation in the therapy of cardiogenic shock: primary results from the multicenter, randomized ECMO-CS trial

07 Nov 2022

Mirvat Alasnag provides her take on the ECMO-CS trial, which was presented during AHA 2022 in Chicago, and simultaneously published in Circulation. 

Dr. Mirvat Alasnag

Author

Mirvat Alasnag
ECMO-CS – Extracorporeal membrane oxygenation in the therapy of cardiogenic shock: primary results from the multicenter, randomized ECMO-CS trial

Percutaneous coronary intervention of native coronary artery versus saphenous vein graft in patients with prior coronary artery bypass graft surgery (PROCTOR)

03 Nov 2025

Kalaivani Mahadevan and Trisha Singh provide their take on the PROCTOR study presented by Ruben de Winter at TCT 2025, in San Francisco.

Kalaivani Mahadevan

Author

Kalaivani Mahadevan
Trish Singh

Author

Trish Singh
PROCTOR: PCI of native coronary artery vs SVGin patients with prior CABG
Didn’t find what you were looking for?